# Adil Daud

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/adil-daud/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,850 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 89 |
| i10-index | 250 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5018322482 |
| ORCID iD | https://orcid.org/0000-0002-6617-8421 |
| Works | 573 |

## Researcher papers

- [A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments](https://scholariq.org/papers/a-natural-killer-dendritic-cell-axis-defines-checkpoint-therapy-responsive-tumor/)
- [Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma](https://scholariq.org/papers/phase-i-trial-of-interleukin-12-plasmid-electroporation-in-patients-with/)
- [Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity](https://scholariq.org/papers/unleashing-type-2-dendritic-cells-to-drive-protective-antitumor-cd4-t-cell/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.